DuPont

Chemours’ When-Issued Shares See Weak Start

Worker Dies at Ineos Nitrile Texas Plant

Chemours Spin-off from DuPont Finalized for July 1

Topics • Technology

New Challenges Demand New Processes

Chemours Closes on Notes, Credit Facilities

EU Denies Holding Back on EDCs Under Pressure

DuPont Faces Fines in Safety Investigation

DuPont Spin-Off Chemours Names Board of Directors

DuPont Wins Battle With Activist Shareholder

Second Proxy Advisor Backs DuPont Activist Shareholder

Proxy Advisory Firm Backs Hedge Fund’s Criticism of DuPont

DuPont to Buy Microbials Specialist Taxon Biosciences

DuPont and Trian Fight for Their Director Candidates

Topics • Strategy

Chemical Players Expect Gains on Cheap Oil and Euro

Axalta Building New Waterborne Coatings Plant in China

DuPont Rejects Activist Investor’s Universal Ballot Request

Activist hedge funds' Assets Swell Six-fold in ten Years

Texas Lawmakers Propose Chemical Information Sharing

DuPont Vents Frustration With Activist Investor

DuPont and Chenguang Link on Fluoroelastomers

DuPont Wins Whistleblower Case Over Leak

DuPont Plans Fresh Share Buyback

Port of Antwerp Supports Major Petchem Investments

Investor Seeks to Nominate Candidates to DuPont Board

EPA Fines DuPont for Clean Air Act Violations

DuPont and Monsanto Bury the Patent Hatchet

Shell JV in Brazil Invests Heavily in Ethanol

India’s SRF Acquires DuPont’s Pharma Propellant Arm

S&W to Buy DuPont Pioneer Alfalfa Seed Business

DuPont Performance Chemicals to be Called Chemours

DuPont Finalizes Sale of Neoprene to Denka

DuPont Under Scrutiny Over Texas Plant Deaths

Sumitomo Acquires DuPont’s US Asana Insecticide Unit

New Jersey Authority Cites DuPont Unit for 11 Violations

US Chemical Output Rises for 10th Straight Month

163 more articles

Top-Feature

Aenova Holding GmbH

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Society of Chemical Manufacturers & Affiliates (SOCMA)

Managm. Consult. Chemicals

DuPont Company

Dechema e.V.

LANXESS Deutschland GmbH

DuPont Intern. Operat. Sarl

American Oil Chemists' Society (AOCS)

Squire Patton Boggs

Dupont International Operations S.àr.l.

International Flavors & Fragrances Inc. (IFF)

Enigma Marketing Research

Camelot Management Consultants AG

Together for Sustanability (TFS)

EDB Singapore

Univers. St. Gallen